Colorectal Cancer Screening
Authors: Christine Laine
Journal: Annals of Internal Medicine (2008)

In the Clinic5 February 2008Colorectal Cancer ScreeningChristine Laine, MD, MPH, David R. Goldmann, MD, and David S. Weinberg, MD, MScChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldmann, MDSearch for more papers by this author, and David S. Weinberg, MD, MScSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-148-3-200802050-01002 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Risk FactorsColorectal cancer is the fourth most common type of cancer and the second leading cause of cancer death in the United States (1). Outside the United States, the impact of colorectal cancer is also immense. In terms of global incidence, it ranks third among cancers affecting women and fourth for men (2). Assuming no improvement in cancer control strategies, colorectal cancer prevalence rates will increase more rapidly than U.S. population growth during the years 2000 to 2020, largely because of population aging (3). Fortunately, ample evidence shows that screening for colorectal cancer with any of several available strategies ...References1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66. [PMID: 17237035] Google Scholar2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. [PMID: 15761078] Google Scholar3. Mariotto AB, Yabroff KR, Feuer EJ, et al. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control. 2006;17:1215-26. [PMID: 17111252] Google Scholar4. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863-72. [PMID: 17079760] Google Scholar5. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-56. [PMID: 11231939] Google Scholar6. Losi L, Di Gregorio C, Pedroni M, et al. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. Am J Gastroenterol. 2005;100:2280-7. [PMID: 16181381] Google Scholar7. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med. 1996;334:82-7. [PMID: 8531963] Google Scholar8. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992-3003. [PMID: 11693338] Google Scholar9. Coups EJ, Manne SL, Meropol NJ, et al. Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev. 2007;16:510-6. [PMID: 17372246] Google Scholar10. Dubé C, Rostom A, Lewin G, et al.; U.S. Preventive Services Task Force. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;146:365-75. [PMID: 17339622] Google Scholar11. Rossouw JE, Anderson GL, Prentice RL, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33. [PMID: 12117397] Google Scholar12. Hulley S, Furberg C, Barrett-Connor E, et al.; HERS Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:58-66. [PMID: 12090863] Google Scholar13. U.S. Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med. 2002;137:834-9. [PMID: 12435221] Google Scholar14. American Cancer Society. Cancer facts and figures 2007. Atlanta: American Cancer Society; 2007. Google Scholar15. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-81. [PMID: 8247072] Google Scholar16. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-71. [PMID: 8474513] Google Scholar17. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7. [PMID: 10070942] Google Scholar18. Jörgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29-32. [PMID: 11772963] Google Scholar19. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-7. [PMID: 8942775] Google Scholar20. Towler BP, Irwig L, Glasziou P, et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2000:CD001216. [PMID: 10796760] Google Scholar21. Collins JF, Lieberman DA, Durbin TE, et al.; Veterans Affairs Cooperative Study #380 Group. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142:81-5. [PMID: 15657155] Google Scholar22. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86-94. [PMID: 15657156] Google Scholar23. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244-55. [PMID: 17310048] Google Scholar24. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-7. [PMID: 1736103] Google Scholar25. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colo-rectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-5. [PMID: 1404450] Google Scholar26. Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med. 1995;123:904-10. [PMID: 7486484] Google Scholar27. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311-8. [PMID: 8340943] Google Scholar28. Berry DP, Clarke P, Hardcastle JD, et al. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg. 1997;84:1274-6. [PMID: 9313712] Google Scholar29. Rasmussen M, Kronborg O, Fenger C, et al. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand J Gastroenterol. 1999;34:73-8. [PMID: 10048736] Google Scholar30. Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001; 345:555-60. [PMID: 11529208] Google Scholar31. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000;342: 1766-72. [PMID: 10852998] Google Scholar32. Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut. 1998;42:560-5. [PMID: 9616321] Google Scholar33. Reilly JM, Ballantyne GH, Fleming FX, et al. Evaluation of the occult blood test in screening for colo-rectal neoplasms. A prospective study using flexible endoscopy. Am Surg. 1990;56:119-23. [PMID: 2316930] Google Scholar34. Johnson DA, Gurney MS, Volpe RJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol. 1990;85:969-74. [PMID: 2375325] Google Scholar35. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-8. [PMID: 10900274] Google Scholar36. Thiis-Evensen E, Hoff GS, Sauar J, et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999; 34:414-20. [PMID: 10365903] Google Scholar37. Citarda F, Tomaselli G, Capocaccia R, et al.; Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812-5. [PMID: 11358901] Google Scholar38. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA. 1994;271:1011-3. [PMID: 8139058] Google Scholar39. Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc. 2007;65:648-56. [PMID: 17173914] Google Scholar40. Fenlon HM, Nunes DP, Schroy PC 3rd, et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999;341:1496-503. [PMID: 10559450] Google Scholar41. Fletcher JG, Johnson CD, Welch TJ, et al. Optimization of CT colonography technique: prospective trial in 180 patients. Radiology. 2000;216:704-11. [PMID: 10966698] Google Scholar42. Miao YM, Amin Z, Healy J, et al. A prospective single centre study comparing computed tomography pneumocolon against colonoscopy in the detection of colo-rectal neoplasms. Gut. 2000;47:832-7. [PMID: 11076883] Google Scholar43. Mendelson RM, Foster NM, Edwards JT, et al. Virtual colonoscopy compared with conventional colonoscopy: a developing technology. Med J Aust. 2000;173:472-5. [PMID: 11149303] Google Scholar44. Yee J, Akerkar GA, Hung RK, et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology. 2001;219:685-92. [PMID: 11376255] Google Scholar45. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349:2191-200. [PMID: 14657426] Google Scholar46. Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colono-graphy (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colo-rectal neoplasia. JAMA. 2004;291: 1713-9. [PMID: 15082698] Google Scholar47. Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007;357:1403-12. [PMID: 17914041] Google Scholar48. Edwards JT, Wood CJ, Mendelson RM, et al. Extracolonic findings at virtual colonoscopy: implications for screening programs. Am J Gastroenterol. 2001;96:3009-12. [PMID: 11693340] Google Scholar49. Regueiro CR; AGA Future Trends Committee. AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies. Gastroenterology. 2005;129:1083-103. [PMID: 16143145] Google Scholar50. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96-104. [PMID: 12118964] Google Scholar51. Agrawal S, Bhupinderjit A, Bhutani MS, et al.; Committee of Minority Affairs and Cultural Diversity, American College of Gastroenterology. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515-23; discussion 514. [PMID: 15743345] Google Scholar52. Lin OS, Kozarek RA, Schembre DB, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006;295:2357-65. [PMID: 16720821] Google Scholar53. Itzkowitz SH, Present DH; Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314-21. [PMID: 15735438] Google Scholar54. Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987;328:614-6. [PMID: 3039373] Google Scholar55. Mills SJ, Chapman PD, Burn J, et al. Endoscopic screening and surgery for familial adenomatous polyposis: dangerous delays. Br J Surg. 1997;84:74-7. [PMID: 9043460] Google Scholar56. Syngal S. Hereditary nonpolyposis colorectal cancer: a call for attention [Editorial]. J Clin Oncol. 2000;18:2189-92. [PMID: 10829037] Google Scholar57. U.S. Preventive Services Task Force. Screening for colo-rectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129-31. [PMID: 12118971] Google Scholar58. American Academy of Family Physicians. Clinical Preventive Services. Accessed at www.aafp.org/online/en/home/clinical/exam.html on 12 December 2007. Google Scholar59. Winawer S, Fletcher R, Rex D, et al.; Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544-60. [PMID: 12557158] Google Scholar60. American Cancer Society. Accessed at www.cancer.org on 12 December 2007. Google Scholar61. American College of Gastroenterology. Clinical Updates. Accessed at www.acg.gi.org/physicians/clinical updates.asp#guidelines on 12 December 2007. Google Scholar62. Davila RE, Rajan E, Baron TH, et al.; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546-57. [PMID: 16564851] Google Scholar63. Meissner HI, Breen N, Klabunde CN, et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389-94. [PMID: 16492934] Google Scholar64. Nichols S, Koch E, Lallemand RC, et al. Randomised trial of compliance with screening for colorectal cancer. Br Med J (Clin Res Ed). 1986;293:107-10. [PMID: 3089411] Google Scholar65. Zapka JG, Lemon SC, Puleo E, et al. Patient education for colon cancer screening: a randomized trial of a video mailed before a physical examination. Ann Intern Med. 2004;141:683-92. [PMID: 15520425] Google Scholar66. Denberg TD, Coombes JM, Byers TE, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med. 2006;145:895-900. [PMID: 17179058] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByKolorektalkarzinom 5 February 2008Volume 148, Issue 3Page: ITC2-1KeywordsAdenomasCancer preventionCancer screeningColonoscopyColorectal cancerColorectal cancer screeningDeath ratesNSAIDs ePublished: 5 February 2008 Issue Published: 5 February 2008 CopyrightCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...